Saturday, December 4, 2021

Two-thirds of Indians have Covid antibodies, says ICMR sero survey

Government today said that around 40 crore population of the country is still vulnerable to COVID19. Briefing reporters in New Delhi, ICMR DG Dr Balram Bhargava said, the 4th round of national sero-survey was conducted in 70 districts in June and July.

The survey was conducted over 28 thousand 975 individuals apart from Seven thousand 252 healthcare workers. He said, the 4th survey design was slightly different from the previous three sero-surveys as children aged 6 to 17 year were included this time.

Mr Bhargava said, the overall sero-prevalence in the entire population is 67.6 per cent. He said, in unvaccinated, the seroprevalence was 62.3 per cent and with one dose of vaccine, it was 81 per cent. The person who receive both the doses of vaccine, the seroprevalence was 89.8 per cent.

He said, there was no difference in seroprevalence in male and female. DG, ICMR said that the survey also revealed that there is not much difference found between rural and urban areas. However, seroprevalence is slightly higher in urban areas.  The overall sero-prevalence in the Health care workers was 85.2 per cent.

Balram Bhargava said, two third of general population had SARS-CoV-2 antibodies. He said, more thanhalf of the children between 6 to 17 years were seropositive. He said, the survey clearly shows that there is a ray of hope and no room for complacency. He said, societal, public, religious and political congregations should be avoided.

NITI Aayog Member, Dr. V.K. Paul said, one out of three people are still vulnerable to COVID19. He sad, the pandemic is in not over and the second wave is still persisting. The danger of new outbreaks is very much there. DR Paul said, the overall vulnerability for the nation still remains.

Dr Paul said, this national-level sero-survey does not fully allow us to understand the state, district and sub-district level dynamics. He strongly recommend there should be timely, high quality sero-surveys to understand specific population level spread of the disease.

- Advertisement -spot_img
Latest news
Related news